Iradimed Corp. (IRMD) Tops Q2 EPS by 5c

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $5.5 million versus the consensus estimate of $5.41 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Hermès can regain momentum despite China weakness, Jefferies says